For the next generation of diagnostics, bodies will become continuous sources of health insights.
South Korean research institute DGIST (July 2026) developed an AI-powered electronic nose combining Metal-Organic Framework (MOF) sensors with machine learning to distinguish thousands of scents. Potential applications include non-invasive disease diagnosis, toxic gas detection and food freshness monitoring.
New York medical research center Feinstein Institutes for Medical Research (July 2026) restored movement and touch in a quadriplegic patient using five implanted microelectrode arrays and an AI decoder. The patient's arm strength increased 86% over 35 weeks, with improvements persisting more than two years after the device was switched off, suggesting lasting neuroplastic changes.
Penn State University, MIT and China's Suzhou Institute of Biomedical Engineering and Technology (July 2026) created a paint-on polymer electrode that maintained 95.1% consistency when measuring heart activity, even during heavy sweating and stretching to 170% of its original size, bringing continuous biometric monitoring closer to everyday use.
The opportunity: creating the trusted data, interpretation and service layers that turn biological signals into decisions clinicians can act on.